The National Cancer Institute (NCI) is offering this grant to encourage revision applications from its currently funded P50 specialized centers. This grant is for the purpose of expanding existing research questions or accelerating parent study progress by integrating novel technical approaches or devices originating from the NCI Innovative Molecular Analysis Technologies (IMAT) program. The NCI aims to incentivize independent validation and hasten the adoption of these emerging technologies within relevant research communities. Ultimately, this opportunity seeks to foster interdisciplinary collaboration, promoting the development of innovative tools and methods vital for advancing cancer research and scientific discovery.
Opportunity ID: 357959
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-25-007 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 31, 2024 |
| Last Updated Date: | Dec 31, 2024 |
| Original Closing Date for Applications: | Oct 03, 2025 |
| Current Closing Date for Applications: | Oct 03, 2025 |
| Archive Date: | Nov 08, 2025 |
| Estimated Total Program Funding: | $150,000 |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Small businesses Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments City or township governments Private institutions of higher education State governments For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to encourage revision applications from currently funded NCI P50 specialized centers. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or device developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this NOFO are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this NOFO aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-25-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357959 Full Announcement-RFA-CA-25-007 -> RFA-CA-25-007-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289854 | Mar 04, 2025 | Oct 03, 2025 | View |
Package 1
Mandatory forms
357959 RR_SF424_5_0-5.0.pdf
357959 PHS398_CoverPageSupplement_5_0-5.0.pdf
357959 RR_OtherProjectInfo_1_4-1.4.pdf
357959 PerformanceSite_4_0-4.0.pdf
357959 RR_KeyPersonExpanded_4_0-4.0.pdf
357959 PHS398_ResearchPlan_5_0-5.0.pdf
357959 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357959 PHS_Additional_IndirectCosts_2_0-2.0.pdf
357959 PHS_AssignmentRequestForm_4_0-4.0.pdf